BACKGROUND AND PURPOSE: Studies have assessed PET by using various tracers to
diagnose disease recurrence in patients with previously treated glioma; however, the …

Posttreatment high-grade gliomas are usually monitored with contrast-enhanced MRI, but its
diagnostic accuracy is limited as it cannot adequately distinguish between true tumor …

PURPOSE: The purpose of the study was to compare the efficacies of FDG PET-CT and
contrast enhanced MRI in detection of recurrent gliomas. METHODS: Ninety …

Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …

Objectives To compare the diagnostic accuracy of contrast enhanced magnetic resonance
imaging (Ce-MRI) and 18 F-fluorodopa (18 F-FDOPA) positron emission tomography (PET) …

Abstract Purpose 18 F-fluorodeoxyglucose (FDG) and 11 C-methionine (MET) PET imaging
studies allow the investigation of metabolism and amino acid transport in brain tumours …

Introduction Radiological assessment of brain tumors is widely based on the Radiology
Assessment of Neuro-Oncology (RANO) criteria that consider non-specific T1 and T2 …

Despite the advancement of neuroimaging techniques, it often remains a diagnostic
challenge to distinguish recurrent glioma from lesions representing treatment effect …

Purpose Reliable differential diagnosis between tumour recurrence and treatment-induced
lesions is required to take advantage of new therapeutic approaches to recurrent gliomas …

Objectives To investigate the value of combined 18F-fluorethyltyrosine-(FET)-PET/MRI for
differentiation between recurrence and treatment-related changes in glioma patients …